• Article highlight
  • Article tables
  • Article images

Article History

Received : 15-06-2023

Accepted : 26-07-2023



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 621

PDF Downloaded: 250


Get Permission Chaudhry: Sex differences in kinetic handling of various therapeutic molecules

Prologue

Women have less body weight, can have higher concentrations of drug, because drugs have lower clearance and/or lesser volume of distribution. The gastric transit time are also shorter in men about 45 hours compared to women 92 hours. Cmax was more in women 87% of the time and AUC was more in women 71% of the time. Bile acid composition is also variable, women have higher concentrations of Chenodeoxycholic acid as compared to Cholic acid in men.1, 2, 3, 4, 5 The Activities of microsomal enzymes of CYPs 1A2 and 2E1 were decreased in women, thus metabolic handling is highly variable. The fatty oxidation is also higher in women as compared to men. Likely Women have better insulin sensitivity as compared to men.

Critical Analysis

Different response of drugs in women is shown by fact that females have a nearly 2-fold greater risk than males for exhibiting Adverse drug reactions (ADR). Women over the age of 19 were 43 - 69% more likely to have an ADR recorded by their general practitioner. Fat composition higher and water content is lower in women. Hence women have different responses to various drugs.6, 7, 8, 9, 10, 11, 12

Table 1

Women have different responses than men

Drug

Results in females

Alfentanil

Decreased Plasma Concentration. Males required 25% higher doses.

Oxazepam / Paracetamol

Increased Plasma Concentration

Metoprolol

Lower hepatic clearance

Methylprednisolone

Higher hepatic clearance

Morphine

Increased effect

Rocuronium / Vecuronium

Increased effect

Propofol

Decreased effect

Desflurane

Females requires 20 % higher dose than men.

Pentazocine

Produces more analgesia in women

Lignocaine

50% larger elimination half life and 62 % larger volume of distribution

Beta Blockers – Propranolol

Clearance was 50 % as compared to males and there is greater reduction in blood pressure in women 

Cimetidine

Intrasubject Bioavailability variation is 16% in males and 10% in females

Erythromycin

C max with erythromycin was 42% higher in men than in women

NSAIDs – Piroxicam

Plasma concentrations of piroxicam increase with aging and women exhibited higher concentrations than men .

Cardiac glycosides – Digoxin

Clearance is 12 % less in women as have lesser Glomerular filtration rate

Antipsychotic Therapy

Clinically superior response in females

Quinolones – Ciprofloxacin

Clearance is lower in women

Aspirin

omen might be less responsive (2.3 times ) to aspirin than men.

Cefotaxime

Clearance is decreased in women.

Cortisol Suppression

Women are more Susceptible

Apixaban

Exposure is 15 % greater in female subjects than in male subjects.

Zolpidem

35% lower apparent clearance of drug.

Gastric emptying and small intestine motility are reduced in pregnancy. Drug absorption is also reduced by nausea and vomiting. Selective serotonin reuptake inhibitors (SSRIs) including fluoxetine, sertraline, and paroxetine. The relative concentrations of these drugs is decreased, though caution is required in pregnancy. The dose requirements for volatile anaesthetic agent, such as halothane, is reduced in pregnancy. Acute liver failure is serious adverse event that occurs more frequently in women. Certain of ADR were also more common in women, such as nausea, alopecia, headache and dizziness, while men were more likely to experience ADRs such as aggression, sexual dysfunction and tendon rupture.  Women undergoing treatment with Clozapine or olanzapine have a remarkably higher risk for metabolic dysfunction but also are more prone for adverse cardiovascular outcomes. Women taking antipsychotics are nearly 4 times more likely to have a prolonged QTc interval than men. 5-fluorouracil (5-FU) difference in its clearance, increases ADR risk in women. Causes for more ADRs in women include: smaller volume of distribution, alteration in receptor binding, lesser BMI in women.

Epilogue

Sex differences are critical for many drugs used in therapeutics. Physicians should be aware of critical dose calculation in females, as significant variability is observed with most therapeutic drugs. For diabetics, glitazones (Pioglitazone) act better in women, whereas sulfonylureas act better in men. Its well known fact that towards vaccination females develop higher antibody response and are prone to more adverse effects, true for the novel SARS-CoV-2 vaccines. Most of the clinical trials for drug evaluation are done in men as female subset is generally excluded. Therefore there is dose disparity in most of the therapeutic groups. It was in only in 1993, the National Institute of Health has approved trials in both sexes with due precautions.

Source of Funding

None.

Conflict of Interest

None.

References

1 

OP Soldin SH Chung DR Mattison Sex Differences in Drug DispositionBiomed Res Int201118710310.1155/2011/187103

2 

OP Soldin MD Mattison Sex Differences in Pharmacokinetics and PharmacodynamicsClin Pharmacokinet200948314357

3 

I Zucker BJ Prendergast Sex differences in pharmacokinetics predict adverse drug reactions in womenBiol Sex Diff20201113210.1186/s13293-020-00308-5

4 

H Pleyum O Spigset O Dale D Kharasch Gender differences in drug effects: implications for anesthesiologistsActa Anesthesiol Scan20034724159

5 

G Koren Sex Dependent Pharmacokinetics and Bioequivalence -Time for ChangeJ Popul Ther Clin Pharmacol201320335861

6 

M Ibarra M Va´zquez P Fagiolino Sex Effect on Average BioequivalenceClin Ther20173912333

7 

EA Poweleit MA Cinibulk SA Novotny MW Schuman LB Ramsey JR Strawn Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy:Clin Res Imp202213833217

8 

M Romanescu Sex-Related Differences in Pharmacological Response to CNS Drugs: A Narrative ReviewJ Pers Med202212690710.3390/jpm12060907

9 

Silvia Mezzalira Giuseppe Toffoli The effects of sex on pharmacogenetically guided drug treatmentPharmacogenomics20212215

10 

FM Jarvis Sex differences in metabolic homeostasis, diabetes, and obesitybBiol Sex Differ2015614

11 

S Fischinger CM Boudreau AL Butler Sex differences in vaccine-induced humoral immunitySemin Immunopathol201941223949

12 

F Franconi S Brunelleschi L Steardo V Cuomo Gender differences in drug responsesPharmacol Res20075528195



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.